Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study
- Conditions
- Type II Diabetes
- Interventions
- Behavioral: Personalized Health Planning Shared Medical Appointment
- Registration Number
- NCT02471794
- Lead Sponsor
- Duke University
- Brief Summary
The primary aim of this study is to examine the feasibility of implementing an evidence based patient engagement strategy, known as personalized health planning (PHP), in the context of a a shared medical appointment (SMA) for individuals with type II diabetes in a primary care setting.
- Detailed Description
All data for the prospective portion of this study was done being collected in September 2016. The retrospective chart review will collect data up until March of 2017 (six months after the last subject completed the prospective phase by attending their last SMA session).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 33
- A diagnosis of Type 2 diabetes within the last year
- A current patient at Duke Family Medicine.
- An A1C score greater than 7 and less than 14.
- A diagnosis of Pre-diabetes
- A diagnosis of Type I diabetes
- Individuals with amputations as a result of their diabetes are excluded form this study.
- Individuals with renal dialysis will not be included in this study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Personalized Health Planning Shared Medical Appointment Personalized Health Planning Shared Medical Appointment The PHP SMA group will combine personalized health planning with a modified version of the standard shared diabetes medical appointment. Modifications include: a self-assessment of health status, greater emphasis on a collaborative patient-provider health goal-setting process, a plan to meet goals, a mindfulness practice included in each session, and the creation of a 'personalized health plan' participant notebook for each individual to document health goals and track progress to review at each session. The participant notebook also includes educational handouts and worksheets to complement the educational curriculum.
- Primary Outcome Measures
Name Time Method Feasibility measured using a patient satisfaction survey 12 months Change in patient activation measured using the patient activation measure baseline; 6 months; 12 months Change in self-management of diabetes self-efficacy using the Diabetes Empowerment Scale baseline; 6 months; 12 months Change in diabetes self efficacy using the 1-item diabetes self-efficacy scale baseline; 6 months; 12 months Change in A1C using the A1C blood test baseline; 3 months; 6 months; 9 months; 12 months
- Secondary Outcome Measures
Name Time Method Change in depression screening score using the Patient Health Questionnaire (PHQ-9) baseline; 6 months; 12 months Change in functional health and well-being using the short form health survey baseline; 6 months; 12 months Change in general self-rated health using the general self rated health survey (GSRH) baseline; 6 months; 12 months Change in health goal progress using a goal progress visual analog scale 3 months; 10 months change in body mass index using weight and height measurements baseline; 1 months; 2 months; 3 months; 5 months; 8 months; 10 months; 12 months change in blood pressure using blood pressure measurement baseline; 1 months; 2 months; 3 months; 5 months; 8 months; 10 months; 12 months Change in low-density lipoprotein cholesterol (LDL) using LDL measurement baseline; 6 months; 12 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Duke Family Medicine Center
🇺🇸Durham, North Carolina, United States